Recro Pharma Inc. (REPH)
NASDAQ: REPH
· Real-Time Price · USD
2.09
-0.01 (-0.48%)
At close: Mar 22, 2022, 5:00 AM
Recro Pharma Revenue
Recro Pharma reported an annual revenue of $94.64M, reflecting a 4.9% growth. For the quarter ending December 31, 2023, Recro Pharma generated $27.72M in revenue.
Revenue (ttm)
$94.64M
Revenue Growth
4.9%
Price / Sales Ratio
2103.12
Revenue / Employee
$511.54K
Employees
185
Market Cap
177.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|